Jun Zhu

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

Medicine, Oncology, Pharmacology +17

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Yan Song, Bo Zhang, Dao Xin et al. · Nature Medicine · 2023 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Area and volume ratios for prediction of visual outcome in idiopathic macular hole

Xing-Yun Geng, Huiqun Wu, Jiehui Jiang et al. · International Journal of Ophthalmology · 2017 · 18 citations · Full text

Medicine, Ophthalmology, Surgery +17

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies

Yizhou Zhang, Ruicheng Wei, Ge Song et al. · mAbs · 2024 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17

Corrective effects of maternal extreme flexure and hip abduction combined with contralateral side‐lying on persistent foetal occipito‐posterior position

Lan‐ping Liu, Jiu‐hong Chen, Zhi‐juan Yang et al. · International Journal of Nursing Practice · 2018 · 12 citations

Medicine, Maternal Health, Obstetrics +13